Rosie A. Harris
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
Journal: The Journal of infection
Published: March 18, 2026
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
Journal: The Journal of infection
Published: March 18, 2026
A comparison of five statistical methods used to analyze longitudinal EORTC QLQ-C30 quality of life scores in randomized controlled trials: a simulation study.
Journal: Journal of clinical epidemiology
Published: October 30, 2025
Survival outcome of VATS compared with open lobectomy for lung cancer: an individual patient data meta-analysis of randomised trials.
Journal: Lancet (London, England)
Published: September 09, 2025
Optimum diagnostic pathway and pathologic confirmation rate of early stage lung cancer: Results from the VIOLET randomised controlled trial.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 06, 2024
Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV).
Journal: Vaccine
Published: May 30, 2024
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial.
Journal: Vaccine
Published: December 22, 2023
A scoping review of statistical methods used to report EORTC QLQ-C30 quality of life scores measured longitudinally.
Journal: BMC medical research methodology
Published: November 22, 2023
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial.
Journal: The Lancet. Respiratory medicine
Published: November 17, 2023
Last Updated: 09/26/2026